Title:
【発明の名称】チオールスルホンアミドヒドロキサム酸化合物
Document Type and Number:
Japanese Patent JP2002513408
Kind Code:
A
Abstract:
An amidoaromatic ring sulfonamide hydroxamic acid compound that inter alia inhibits matrix metalloprotease activity is disclosed, as are a treatment process that comprises administering a contemplated amidoaromatic ring sulfonamide hydroxamic acid compound in a MMP enzyme-inhibiting effective amount to a host having a condition associated with pathological matrix metalloprotease activity.
Inventors:
Getman, Daniel, Pea.
Becker, Daniel, Pea.
Balta, Thomas, Yi.
Villamil, Clara, Ai.
Hockerman, Susan, Elle.
Bedel, Lewis, Jay.
Lee, Madeleine, H.
Frescos, John, N.
Heinz, Robert, M.
McDonald's, Joseph, Jay.
Decresenzo, Gary, A.
Becker, Daniel, Pea.
Balta, Thomas, Yi.
Villamil, Clara, Ai.
Hockerman, Susan, Elle.
Bedel, Lewis, Jay.
Lee, Madeleine, H.
Frescos, John, N.
Heinz, Robert, M.
McDonald's, Joseph, Jay.
Decresenzo, Gary, A.
Application Number:
JP53879798A
Publication Date:
May 08, 2002
Filing Date:
March 04, 1998
Export Citation:
Assignee:
Monsanto Company
International Classes:
A61K31/18; A61K31/197; A61K31/216; A61K31/27; A61K31/36; A61K31/381; A61K31/40; A61K31/423; A61K31/426; A61K31/44; A61K31/4402; A61K31/4406; A61K31/4409; A61K31/443; A61K31/4436; A61K31/4439; A61K31/444; A61K31/445; A61K31/4453; A61K31/4465; A61K31/4545; A61K31/535; A61K31/5375; A61K31/5377; A61K31/55; A61P1/04; A61P7/02; A61P7/04; A61P9/00; A61P9/02; A61P9/10; A61P13/12; A61P17/02; A61P19/02; A61P19/08; A61P25/00; A61P25/28; A61P27/02; A61P29/00; A61P35/00; A61P35/04; A61P43/00; C07C311/46; C07C323/67; C07D207/08; C07D209/18; C07D209/48; C07D211/14; C07D211/22; C07D213/30; C07D213/32; C07D213/38; C07D249/12; C07D213/42; C07D213/70; C07D213/81; C07D213/82; C07D215/36; C07D233/42; C07D233/64; C07D235/28; C07D239/38; C07D239/93; C07D241/12; C07D257/04; C07D263/46; C07D263/58; C07D265/30; C07D271/10; C07D277/20; C07D277/24; C07D277/26; C07D277/36; C07D277/56; C07D277/78; C07D285/08; C07D285/125; C07D295/12; C07D295/13; C07D295/14; C07D295/18; C07D307/38; C07D307/64; C07D307/68; C07D307/79; C07D309/12; C07D317/56; C07D317/62; C07D333/18; C07D333/34; C07D333/38; C07D333/54; C07D401/04; C07D401/12; C07D405/04; C07D409/04; C07D409/12; C07D413/04; C07D413/12; C07D417/12; C07D471/04; C07D513/04; H04N7/088; (IPC1-7): C07D295/12; A61K31/18; A61K31/40; A61K31/4402; A61K31/4406; A61K31/4409; A61K31/4453; A61K31/5375; A61K31/5377; A61K31/55; A61P7/02; A61P7/04; A61P9/00; A61P9/02; A61P29/00; A61P43/00; C07D209/18; C07D209/48; C07D213/32; C07D213/38; C07D213/70; C07D215/36; C07D233/42; C07D233/64; C07D235/28; C07D239/38; C07D239/93; C07D241/12; C07D249/12; C07D257/04; C07D263/46; C07D263/58; C07D271/10; C07D277/36; C07D277/78; C07D285/08; C07D285/125; C07D307/38; C07D307/64; C07D307/79; C07D317/56; C07D317/62; C07D333/18; C07D333/34; C07D333/54; C07D401/04; C07D405/04; C07D409/04; C07D413/04; C07D471/04; C07D513/04
Attorney, Agent or Firm:
Akira Asamura (3 outside)